Envista Holdings (NVST) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Oct 02 2026 to Sep 26 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Envista Holdings Corporation  (NYSE: NVST)


Envista Holdings's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Envista Holdings's ROA in the third quarter of 2026?
Envista Holdings Corporation achieved a return on average assets (ROA) of 11.24 % in its third quarter of 2026, this is above NVST's average return on assets of -1.07%.
Envista Holdings Corporations assets during the 12 months ending in the third quarter of 2026 are valued at $5 billion

ROA has improved compared to 1.7% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector 193 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Oct 02 2026 quarter, so far to 2112, from total ROA ranking in the second quarter of 2026 at 2637.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Oct 02 2026)
III. Quarter		 (Jul 03 2026)
II. Quarter		 (Apr 03 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 26 2025)
III. Quarter
Y / Y Total Assets Change 2.85 % 2.23 % 4.65 % 9 % 2.34 %
Y / Y Net Income Change - 103.41 % 115 % 2641.67 % -
Net Income (TTM) in million 634 95 68 47 15
Return On Assets (TTM) 11.24 % 1.7 % 1.22 % 0.85 % 0.28 %
NVST's Total Ranking # 2112 # 2637 # 2498 # 2189 # 3656
Total Assets (TTM) in million 5,653 5,648 5,578 5,679 5,496
Seq. Total Assets Change 0.09 % 1.25 % -1.78 % 3.33 % -0.51 %
Seq. Net Income Change 846.55 % 38.76 % 17.63 % - -

NVST's 5 Years Annual ROA >> Back to NVST Management Effectiveness >> Compare NVST ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 61
Sector # 194
Overall # 1899

Return On Assets Statistics
High Average Low
5.53 %
-1.07 %
-22.18 %
(Oct 01 2021)   (Sep 27 2024)





Financial Statements
Envista Holdings's Assets $ 5,653 million NVST's Balance sheet
Envista Holdings's Income $ 508 million Quarterly NVST's Income Statement
NVST's Income by Division See NVST's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 9 % -19.62 % 0.36 % 0.17 % -3.95 %
Total Assets in million 5,679 5,210 6,482 6,459 6,447
Y / Y Net Income Change - - - -28.6 % 922.52 %
Net Income in million 47 -1,119 -100 243 341
Annual Return On Assets 0.83 % -21.47 % -1.55 % 3.76 % 5.28 %

NVST's 5 Years Annual ROA >> Back to NVST Management Effectiveness >> Compare NVST ROA to its Competitors



Comment on NVST's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 0.83 % compared to prior year, due to annual net income growth of % to $47.00 million, while value of Envista Holdings's overall assets grew just by 9 % to $5,679.00 million, compared to $5,679.00 a year before.


More Return On Assets Ratios
NVST's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
NVST's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NVST's Competitors
Subscribers only: Roa for Envista Holdings's Suppliers
Subscribers only: Return On Assets for NVST's Customers

You may also want to know
NVST's Roi NVST's Inventory Turnover Ratio NVST's Growth Rates NVST's Dividend Comparisons
NVST's Profitability Ratios NVST's Asset Turnover Ratio NVST's Dividend Growth
NVST's Roe NVST's Valuation Ratios NVST's Financial Strength Ratios NVST's Dividend Payout Ratio



Companies with similar Return On Assets at Oct 02 2026, within Healthcare Sector ROA
Zevra Therapeutics Inc   26.33 %
Caredx Inc   25.74 %
Medpace Holdings Inc   24.47 %
Acadia Pharmaceuticals Inc   21.60 %
Standard Biotools Inc   21.56 %
Eli Lilly And Company  21.24 %
Iradimed Corporation  20.89 %
Resmed Inc   18.67 %
Alector Inc   18.37 %
Corcept Therapeutics Inc  18.09 %
Chemed Corporation  17.73 %
Halozyme Therapeutics Inc   17.26 %
Pro dex Inc   16.75 %
Denali Therapeutics Inc   16.42 %
Krystal Biotech Inc   15.48 %
West Pharmaceutical Services Inc   15.47 %
Dexcom Inc   15.47 %
Intuitive Surgical Inc   14.71 %
Vertex Pharmaceuticals Inc  14.16 %
Neurocrine Biosciences Inc   13.69 %
Illumina Inc   13.43 %
Healthcare Services Group Inc   12.79 %
Kiniksa Pharmaceuticals International Plc  12.64 %
Tenet Healthcare Corp  12.39 %
Hca Healthcare Inc   11.73 %
Carlisle Companies Incorporated  11.72 %
Regeneron Pharmaceuticals Inc   11.50 %
Lantheus Holdings Inc   11.43 %
Msa Safety Inc  11.01 %
Encompass Health Corporation  10.99 %

Date modified: 2026-11-07T13:24:00+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.